
This review of the latest dermatological studies includes insights on ruxolitinib for lichen planus, early vitiligo treatment, psoriasis response, AD disease control, and PFB management.
When it's time for dermatologic therapy, having an array of treatments from which to choose is vital, according to Stephen P. Stone, M.D., Southern Illinois University School of Medicine. Some of his pearls include the following suggestions:
When it's time for dermatologic therapy, having an array of treatments from which to choose is vital, according to Stephen P. Stone, M.D., Southern Illinois University School of Medicine. Some of his pearls include the following suggestions:
While some of these treatment modalities have received formal U.S. Food and Drug Administration approval, others have not-and all are currently off label.




